Personalized Addiction Care

Paul Schankman & Ron Watermon • October 16, 2020

Innovative & Individualized Treatment

St. Louis, MO- October 2020 – Over the years, the staff at INSynergyhave heard a similar refrain from their patients. Despite having tried multiple inpatient, out-of-town addiction care clinics, INSynergy’spersonalized approach to outpatient treatment finally freed them from the yoke of alcohol and drug addiction.

“It is just so empowering,” said Tom, who turned to INSynergywhen his social drinking became life-destroying. “It’s not a matter of weakness, it’s a matter of trying to figure out what’s the root cause of your issue.”


Tom’s case is a perfect illustration of what makes INSynergy’sprogram so successful. I NSynergy’spersonalized, medically-based approach revealed that Tom was suffering from an undiagnosed Attention Deficit Disorder. Once he was prescribed medication for his ADHD, he was able to concentrate on successfully beating his addiction.

“It’s a very comprehensive approach,” said Ashley Halker, INSynergy’s Director of Operations. “Treating a patient’s addiction as a primary diagnosis, but also making sure we understand that it is a symptom of something else.”

“We try to find what’s really going on with their whole life,” said Arturo Taca, M.D., INSynergy’s founder and Medical Director “Not only do we use principles in addiction medicine, but we take psychiatry, we take neurology, we take pain medicine, we take sleep medicine, we take all these great principles from other fields and combine them and we get a better result.”

INSynergy also brings families into the process to help patients achieve long-term sobriety.

INSynergy’s innovative approach to addiction care includes genetic screening to determine what medications might assist a patient maintain abstinence. INSynergy has also pioneered the development and use of FDA-cleared neuromodulation devicesdesigned to interfere with the pain signals associated with opioid withdrawal, setting patients up for successful post-detox care.

Some patients achieve success through INSynergy’s Vivitrol® clinic, a once-a-month injection which also temporarily blocks opioid and alcohol cravings.

“We like to take pride in being the first people locally to implement the new discoveries in the field of addiction medicine,” Dr. Taca said.

“We invest in our patients, just like they are investing in us,” Halker said.“They are not just surviving, but they’re thriving.”

For more information about INSynergy, including a no-obligation, free, individual assessment, go to INSynergystl.com.


-----Paul Schankman, (SVN) reporting for INSynergy

By Ron Watermon September 7, 2026
What Hugh Howey's Story Can Teach Us
By Ron Watermon September 4, 2026
NETFLIX's INSTADOCS Series Is Collapsing the Distance Between Journalism and Documentary Filmmaking - Offering a Lesson In What It Takes to Tell Stories at the Speed of News
By Ron Watermon September 1, 2026
What's the difference between an amateur and a professional filmmaker?
By Ron Watermon August 26, 2026
The truth between the facts.
By Ron Watermon August 11, 2026
What the Brink of War Can Teach Us About Using Declassified History to Tell a Compelling True Story
By Ron Watermon August 5, 2026
What filmmakers can learn from a century-old media property that turned one live broadcast into a family entertainment ecosystem.
By Ron Watermon August 1, 2026
What Nashville Taught Me About Filmmaking
By Ron Watermon July 28, 2026
Why great stories don't need more freedom. They need better constraints.
By Ron Watermon July 21, 2026
STORYSMART to Help Filmmaker Art Holliday Finish Johnnie Be Good Documentary 22 Years in the Making
By Ron Watermon July 15, 2026
What Young Washington , Hamilton , and The Odyssey teach us about how stories become IP.
Show More